IGMS News

Five health and tech companies went public this week, and each finished the week up at least 20%. One SPAC also IPO'd. Three companies and one SPAC submitted initial filings. After weeks of nonstop news coverage, The We Company (WE) delayed its IPO to the 4Q19. Another mega IPO, Airbnb, announced it would seek public markets in 2020. The leader of the pack was...read more

IGM Biosciences, a Phase 1/preclinical immuno-oncology biotech developing engineered antibodies, raised $175 million by offering 10.9 million shares at $16, within the $15 to $17 range. Insiders had planned to purchase $100 million of the IPO (57% of the deal). IGM Biosciences plans to list on the Nasdaq under the symbol IGMS. Jefferies, Piper Jaffray, Stifel and...read more

IGM Biosciences, a Phase 1/preclinical immuno-oncology biotech developing engineered antibodies, raised the proposed deal size for its upcoming IPO on Tuesday. The Mountain View, CA-based company now plans to raise $175 million by offering 10.9 million shares at a price range of $15 to $17. Insiders intend to purchase $100 million worth of shares in the offering, up from $50...read more

Five IPOs and one SPAC plan to raise $1.7 billion in the week ahead. Rumors are swirling that The We Company (WE) will launch its long-awaited IPO.  Datadog (DDOG) will join the year's growing list of VC-backed tech companies going public at $5+ billion market caps (UBER, LYFT, WORK, PINS, CRWD). The company targets $492...read more